_id
691b128d3c536f8df2318ac6
Ticker
ALVIO.PA
Name
Valerio Therapeutics
Exchange
PA
Address
49, boulevard du GEnEral Martial Valin, Paris, France, 75015
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://valeriotx.com
Description
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes. The company develops developing VIO-01, which is in Phase 1/2 of the VIO-01 clinical study, a Pan-DDR DNA decoy targeting multiple proteins and repair pathways in preclinical development; and PlatON, generates DecoyTAC combining DNA decoy molecules capable of cell penetration with a linker+E3 ligand. It also develops V-body platform, a bispecifics, ADCs, CAR-T, and V-body-oligonucleotide conjugates. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.
Last Close
0.1065
Volume
3679818
Current Price
0.152
Change
40.84507042253521
Last Updated
2025-12-30T12:44:00.407Z
Image
https://logo.clearbit.com/valeriotx.com
Ipo Date
-
Market Cap
69922760
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
126000
Cost Of Revenue
1994000
Gross Profit
-1868000
Operating Expenses
287000
Operating Income
-2155000
Interest Expense
299000
Pretax Income
-670000
Net Income
-208000
Eps
-0.0013474620516626928
Dividends Per Share
-
Shares Outstanding
499448301
Income Tax Expense
-462000
EBITDA
-104000
Operating Margin
-1710.3174603174605
Total Other Income Expense Net
1485000
Cash
2638000
Short Term Investments
-
Receivables
4723000
Inventories
-
Total Current Assets
7353000
Property Plant Equipment
1046000
Total Assets
20443000
Payables
4086999
Short Term Debt
11247000
Long Term Debt
-
Total Liabilities
28894000
Equity
-9117000
Bs_currency_symbol
-
Depreciation
268000
Change In Working Capital
-3861000
Cash From Operations
-3602000
Capital Expenditures
107000
Cash From Investing
38000
Cash From Financing
5029000
Net Change In Cash
1460000
Cf_currency_symbol
-
PE
-
PB
-2.573584457167928
ROE
2.2814522320938906
ROA
-1.0174631903340998
FCF
-3709000
Fcf Percent
-29.436507936507937
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
1
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
5.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
126000
Quarters > 0 > income Statement > cost Of Revenue
1994000
Quarters > 0 > income Statement > gross Profit
-1868000
Quarters > 0 > income Statement > operating Expenses
287000
Quarters > 0 > income Statement > operating Income
-2155000
Quarters > 0 > income Statement > interest Expense
299000
Quarters > 0 > income Statement > pretax Income
-670000
Quarters > 0 > income Statement > net Income
-208000
Quarters > 0 > income Statement > eps
-0.0013474620516626928
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
154364273
Quarters > 0 > income Statement > income Tax Expense
-462000
Quarters > 0 > income Statement > EBITDA
-104000
Quarters > 0 > income Statement > operating Margin
-1710.3174603174605
Quarters > 0 > income Statement > total Other Income Expense Net
1485000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2638000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4723000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7353000
Quarters > 0 > balance Sheet > property Plant Equipment
1046000
Quarters > 0 > balance Sheet > total Assets
20443000
Quarters > 0 > balance Sheet > payables
4086999
Quarters > 0 > balance Sheet > short Term Debt
11247000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
28894000
Quarters > 0 > balance Sheet > equity
-9117000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-208000
Quarters > 0 > cash Flow > depreciation
268000
Quarters > 0 > cash Flow > change In Working Capital
-3861000
Quarters > 0 > cash Flow > cash From Operations
-3602000
Quarters > 0 > cash Flow > capital Expenditures
107000
Quarters > 0 > cash Flow > cash From Investing
38000
Quarters > 0 > cash Flow > cash From Financing
5029000
Quarters > 0 > cash Flow > net Change In Cash
1460000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0013474620516626928
Quarters > 0 > ratios > PB
-2.573584457167928
Quarters > 0 > ratios > ROE
2.2814522320938906
Quarters > 0 > ratios > ROA
-1.0174631903340998
Quarters > 0 > ratios > FCF
-3709000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-29.436507936507937
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1704000
Quarters > 1 > income Statement > cost Of Revenue
4580000
Quarters > 1 > income Statement > gross Profit
-2876000
Quarters > 1 > income Statement > operating Expenses
3031000
Quarters > 1 > income Statement > operating Income
-5907000
Quarters > 1 > income Statement > interest Expense
253000
Quarters > 1 > income Statement > pretax Income
-12850000
Quarters > 1 > income Statement > net Income
-12973000
Quarters > 1 > income Statement > eps
-0.08430698214725406
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
153878121
Quarters > 1 > income Statement > income Tax Expense
123000
Quarters > 1 > income Statement > EBITDA
-2963000
Quarters > 1 > income Statement > operating Margin
-346.6549295774648
Quarters > 1 > income Statement > total Other Income Expense Net
-6943000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
1178000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1732000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4569000
Quarters > 1 > balance Sheet > property Plant Equipment
1172000
Quarters > 1 > balance Sheet > total Assets
17929000
Quarters > 1 > balance Sheet > payables
5247000
Quarters > 1 > balance Sheet > short Term Debt
7622000
Quarters > 1 > balance Sheet > long Term Debt
5630000
Quarters > 1 > balance Sheet > total Liabilities
26194000
Quarters > 1 > balance Sheet > equity
-8930000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-12973000
Quarters > 1 > cash Flow > depreciation
1611000
Quarters > 1 > cash Flow > change In Working Capital
-6240000
Quarters > 1 > cash Flow > cash From Operations
-5627000
Quarters > 1 > cash Flow > capital Expenditures
279000
Quarters > 1 > cash Flow > cash From Investing
-1353000
Quarters > 1 > cash Flow > cash From Financing
22000
Quarters > 1 > cash Flow > net Change In Cash
-2825000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.08430698214725406
Quarters > 1 > ratios > PB
-2.619202059574468
Quarters > 1 > ratios > ROE
145.2743561030235
Quarters > 1 > ratios > ROA
-72.35763288526968
Quarters > 1 > ratios > FCF
-5906000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.465962441314554
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
89000
Quarters > 2 > income Statement > cost Of Revenue
163000
Quarters > 2 > income Statement > gross Profit
-74000
Quarters > 2 > income Statement > operating Expenses
10851000
Quarters > 2 > income Statement > operating Income
-10925000
Quarters > 2 > income Statement > interest Expense
60000
Quarters > 2 > income Statement > pretax Income
-11658000
Quarters > 2 > income Statement > net Income
-10958000
Quarters > 2 > income Statement > eps
-0.06684391752497579
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
163934138
Quarters > 2 > income Statement > income Tax Expense
-700000
Quarters > 2 > income Statement > EBITDA
-9427000
Quarters > 2 > income Statement > operating Margin
-12275.280898876405
Quarters > 2 > income Statement > total Other Income Expense Net
-733000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
4003000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3694000
Quarters > 2 > balance Sheet > inventories
-3336000
Quarters > 2 > balance Sheet > total Current Assets
8730000
Quarters > 2 > balance Sheet > property Plant Equipment
1299000
Quarters > 2 > balance Sheet > total Assets
29341000
Quarters > 2 > balance Sheet > payables
3623000
Quarters > 2 > balance Sheet > short Term Debt
1628000
Quarters > 2 > balance Sheet > long Term Debt
11429000
Quarters > 2 > balance Sheet > total Liabilities
25319000
Quarters > 2 > balance Sheet > equity
4022000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-10958000
Quarters > 2 > cash Flow > depreciation
1680000
Quarters > 2 > cash Flow > change In Working Capital
2149000
Quarters > 2 > cash Flow > cash From Operations
-6833000
Quarters > 2 > cash Flow > capital Expenditures
40000
Quarters > 2 > cash Flow > cash From Investing
-36000
Quarters > 2 > cash Flow > cash From Financing
4187998
Quarters > 2 > cash Flow > net Change In Cash
-2815000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.06684391752497579
Quarters > 2 > ratios > PB
6.195422420686225
Quarters > 2 > ratios > ROE
-272.4515166583789
Quarters > 2 > ratios > ROA
-37.34705701918817
Quarters > 2 > ratios > FCF
-6873000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-77.2247191011236
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
44500
Quarters > 3 > income Statement > cost Of Revenue
81500
Quarters > 3 > income Statement > gross Profit
-37000
Quarters > 3 > income Statement > operating Expenses
5425500
Quarters > 3 > income Statement > operating Income
-5462500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5479000
Quarters > 3 > income Statement > net Income
-5479000
Quarters > 3 > income Statement > eps
-0.033421958762487894
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
163934138
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-4713500
Quarters > 3 > income Statement > operating Margin
-12275.280898876405
Quarters > 3 > income Statement > total Other Income Expense Net
-16500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
4003000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
8730000
Quarters > 3 > balance Sheet > property Plant Equipment
1299000
Quarters > 3 > balance Sheet > total Assets
29341000
Quarters > 3 > balance Sheet > payables
3623000
Quarters > 3 > balance Sheet > short Term Debt
1628000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
25319000
Quarters > 3 > balance Sheet > equity
4022000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-5479000
Quarters > 3 > cash Flow > depreciation
840000
Quarters > 3 > cash Flow > change In Working Capital
1074500
Quarters > 3 > cash Flow > cash From Operations
-3416500
Quarters > 3 > cash Flow > capital Expenditures
20000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2093999
Quarters > 3 > cash Flow > net Change In Cash
-1417501
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.033421958762487894
Quarters > 3 > ratios > PB
6.195422420686225
Quarters > 3 > ratios > ROE
-136.22575832918946
Quarters > 3 > ratios > ROA
-18.673528509594085
Quarters > 3 > ratios > FCF
-3436500
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-77.2247191011236
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1793000
Annuals > 0 > income Statement > cost Of Revenue
513000
Annuals > 0 > income Statement > gross Profit
1280000
Annuals > 0 > income Statement > operating Expenses
17769000
Annuals > 0 > income Statement > operating Income
-16489000
Annuals > 0 > income Statement > interest Expense
313000
Annuals > 0 > income Statement > pretax Income
-23553000
Annuals > 0 > income Statement > net Income
-23931000
Annuals > 0 > income Statement > eps
-0.15551918521282176
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
153878121
Annuals > 0 > income Statement > income Tax Expense
377000
Annuals > 0 > income Statement > EBITDA
-12062000
Annuals > 0 > income Statement > operating Margin
-919.6319018404909
Annuals > 0 > income Statement > total Other Income Expense Net
-7064000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
1178000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1732000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4569000
Annuals > 0 > balance Sheet > property Plant Equipment
1172000
Annuals > 0 > balance Sheet > total Assets
17929000
Annuals > 0 > balance Sheet > payables
5247000
Annuals > 0 > balance Sheet > short Term Debt
7622000
Annuals > 0 > balance Sheet > long Term Debt
5630000
Annuals > 0 > balance Sheet > total Liabilities
26194000
Annuals > 0 > balance Sheet > equity
-8930000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-23931000
Annuals > 0 > cash Flow > depreciation
11314000
Annuals > 0 > cash Flow > change In Working Capital
-4091000
Annuals > 0 > cash Flow > cash From Operations
-12460000
Annuals > 0 > cash Flow > capital Expenditures
319000
Annuals > 0 > cash Flow > cash From Investing
-1389000
Annuals > 0 > cash Flow > cash From Financing
4210000
Annuals > 0 > cash Flow > net Change In Cash
-5663000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.15551918521282176
Annuals > 0 > ratios > PB
-2.5933546708286674
Annuals > 0 > ratios > ROE
267.98432250839863
Annuals > 0 > ratios > ROA
-133.47649060181828
Annuals > 0 > ratios > FCF
-12779000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-7.1271611823759065
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1800000
Annuals > 1 > income Statement > cost Of Revenue
533000
Annuals > 1 > income Statement > gross Profit
1267000
Annuals > 1 > income Statement > operating Expenses
21555000
Annuals > 1 > income Statement > operating Income
-20288000
Annuals > 1 > income Statement > interest Expense
66000
Annuals > 1 > income Statement > pretax Income
-20327000
Annuals > 1 > income Statement > net Income
-20344000
Annuals > 1 > income Statement > eps
-0.15000000073731815
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
135626666
Annuals > 1 > income Statement > income Tax Expense
17000
Annuals > 1 > income Statement > EBITDA
-18444000
Annuals > 1 > income Statement > operating Margin
-1127.111111111111
Annuals > 1 > income Statement > total Other Income Expense Net
-39000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
6818000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1895000
Annuals > 1 > balance Sheet > inventories
6000
Annuals > 1 > balance Sheet > total Current Assets
12995000
Annuals > 1 > balance Sheet > property Plant Equipment
1529000
Annuals > 1 > balance Sheet > total Assets
35274000
Annuals > 1 > balance Sheet > payables
2458000
Annuals > 1 > balance Sheet > short Term Debt
1779000
Annuals > 1 > balance Sheet > long Term Debt
6906000
Annuals > 1 > balance Sheet > total Liabilities
20469000
Annuals > 1 > balance Sheet > equity
14805000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-20344000
Annuals > 1 > cash Flow > depreciation
507000
Annuals > 1 > cash Flow > change In Working Capital
-665000
Annuals > 1 > cash Flow > cash From Operations
-18597000
Annuals > 1 > cash Flow > capital Expenditures
183000
Annuals > 1 > cash Flow > cash From Investing
-177000
Annuals > 1 > cash Flow > cash From Financing
10759000
Annuals > 1 > cash Flow > net Change In Cash
-7771000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.15000000073731815
Annuals > 1 > ratios > PB
1.3787107891252954
Annuals > 1 > ratios > ROE
-137.41303613644038
Annuals > 1 > ratios > ROA
-57.674207631683394
Annuals > 1 > ratios > FCF
-18780000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-10.433333333333334
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1443000
Annuals > 2 > income Statement > cost Of Revenue
514000
Annuals > 2 > income Statement > gross Profit
929000
Annuals > 2 > income Statement > operating Expenses
17656000
Annuals > 2 > income Statement > operating Income
-17115000
Annuals > 2 > income Statement > interest Expense
2197000
Annuals > 2 > income Statement > pretax Income
-19273000
Annuals > 2 > income Statement > net Income
-19562000
Annuals > 2 > income Statement > eps
-0.18499044881130255
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
105746000
Annuals > 2 > income Statement > income Tax Expense
285000
Annuals > 2 > income Statement > EBITDA
-17037000
Annuals > 2 > income Statement > operating Margin
-1186.0706860706862
Annuals > 2 > income Statement > total Other Income Expense Net
-2158000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
14586000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1479000
Annuals > 2 > balance Sheet > inventories
744000
Annuals > 2 > balance Sheet > total Current Assets
20579000
Annuals > 2 > balance Sheet > property Plant Equipment
1887000
Annuals > 2 > balance Sheet > total Assets
43086000
Annuals > 2 > balance Sheet > payables
3449000
Annuals > 2 > balance Sheet > short Term Debt
1338000
Annuals > 2 > balance Sheet > long Term Debt
8104000
Annuals > 2 > balance Sheet > total Liabilities
20816000
Annuals > 2 > balance Sheet > equity
22270000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-19562000
Annuals > 2 > cash Flow > depreciation
-167000
Annuals > 2 > cash Flow > change In Working Capital
6875000
Annuals > 2 > cash Flow > cash From Operations
-9443000
Annuals > 2 > cash Flow > capital Expenditures
488000
Annuals > 2 > cash Flow > cash From Investing
-409000
Annuals > 2 > cash Flow > cash From Financing
6463000
Annuals > 2 > cash Flow > net Change In Cash
-3301000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.18499044881130255
Annuals > 2 > ratios > PB
0.7146283340817243
Annuals > 2 > ratios > ROE
-87.84014369106421
Annuals > 2 > ratios > ROA
-45.402218818177595
Annuals > 2 > ratios > FCF
-9931000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-6.882189882189882
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4062000
Annuals > 3 > income Statement > cost Of Revenue
368000
Annuals > 3 > income Statement > gross Profit
3694000
Annuals > 3 > income Statement > operating Expenses
8837000
Annuals > 3 > income Statement > operating Income
-7327000
Annuals > 3 > income Statement > interest Expense
1214000
Annuals > 3 > income Statement > pretax Income
-7582000
Annuals > 3 > income Statement > net Income
-5937000
Annuals > 3 > income Statement > eps
-0.06730506070345113
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
88210306
Annuals > 3 > income Statement > income Tax Expense
100000
Annuals > 3 > income Statement > EBITDA
-5857000
Annuals > 3 > income Statement > operating Margin
-180.37912358444117
Annuals > 3 > income Statement > total Other Income Expense Net
-255000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
17887000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8540000
Annuals > 3 > balance Sheet > inventories
1451000
Annuals > 3 > balance Sheet > total Current Assets
30133000
Annuals > 3 > balance Sheet > property Plant Equipment
2237000
Annuals > 3 > balance Sheet > total Assets
53063000
Annuals > 3 > balance Sheet > payables
2832000
Annuals > 3 > balance Sheet > short Term Debt
3424000
Annuals > 3 > balance Sheet > long Term Debt
5083000
Annuals > 3 > balance Sheet > total Liabilities
20121000
Annuals > 3 > balance Sheet > equity
32942000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-5937000
Annuals > 3 > cash Flow > depreciation
511000
Annuals > 3 > cash Flow > change In Working Capital
-4136000
Annuals > 3 > cash Flow > cash From Operations
-8572000
Annuals > 3 > cash Flow > capital Expenditures
139000
Annuals > 3 > cash Flow > cash From Investing
-66000
Annuals > 3 > cash Flow > cash From Financing
11976000
Annuals > 3 > cash Flow > net Change In Cash
3363000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.06730506070345113
Annuals > 3 > ratios > PB
0.403000760518487
Annuals > 3 > ratios > ROE
-18.022585149656972
Annuals > 3 > ratios > ROA
-11.18858715112225
Annuals > 3 > ratios > FCF
-8711000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.1445100935499752
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.0013474620516626928
Valuation > metrics > PB
-2.573584457167928
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
2.2814522320938906
Profitability > metrics > ROA
-2.8287773697810414
Profitability > metrics > Net Margin
-1.6507936507936507
Profitability > final Score
5
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-7.207357859531773
Risk > final Score
1
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.4795226607227508
Liquidity > metrics > Quick Ratio
0.4795226607227508
Liquidity > final Score
34
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-63
Prev Risks > 1
-722
Prev Risks > 2
-23
Prev Liquidities > 0
28
Prev Liquidities > 1
92
Prev Liquidities > 2
92
Updated At
2026-01-20T23:09:20.780Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-28
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.09
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-10-01
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.07
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.07
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-04-30
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-12-31
Earnings History > 4 > report Date
2024-03-28
Earnings History > 4 > date
2023-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-09-30
Earnings History > 5 > report Date
2023-10-27
Earnings History > 5 > date
2023-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-06-30
Earnings History > 6 > report Date
2023-07-06
Earnings History > 6 > date
2023-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-03-31
Earnings History > 7 > report Date
2023-04-24
Earnings History > 7 > date
2023-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.18
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.18
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-09-30
Earnings History > 8 > report Date
2022-11-30
Earnings History > 8 > date
2022-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-06-30
Earnings History > 9 > report Date
2022-09-13
Earnings History > 9 > date
2022-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.1
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.1
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-03-31
Earnings History > 10 > report Date
2022-04-06
Earnings History > 10 > date
2022-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-09-30
Earnings History > 11 > report Date
2021-10-29
Earnings History > 11 > date
2021-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-06-30
Earnings History > 12 > report Date
2021-07-29
Earnings History > 12 > date
2021-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.05
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-04-21
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.03
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-09-30
Earnings History > 14 > report Date
2020-10-22
Earnings History > 14 > date
2020-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2020-06-30
Earnings History > 15 > report Date
2020-09-17
Earnings History > 15 > date
2020-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0.06
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.06
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-03-31
Earnings History > 16 > report Date
2020-04-17
Earnings History > 16 > date
2020-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.38
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.38
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-09-30
Earnings History > 17 > report Date
2019-10-24
Earnings History > 17 > date
2019-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2019-06-30
Earnings History > 18 > report Date
2019-07-25
Earnings History > 18 > date
2019-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.15
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.15
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2019-03-31
Earnings History > 19 > report Date
2019-04-17
Earnings History > 19 > date
2019-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-12-31
Earnings History > 20 > report Date
2019-03-12
Earnings History > 20 > date
2018-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.01
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.01
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2018-09-30
Earnings History > 21 > report Date
2018-10-25
Earnings History > 21 > date
2018-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2018-06-30
Earnings History > 22 > report Date
2018-07-27
Earnings History > 22 > date
2018-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.17
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.17
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2018-03-31
Earnings History > 23 > report Date
2018-05-16
Earnings History > 23 > date
2018-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-12-31
Earnings History > 24 > report Date
2018-03-29
Earnings History > 24 > date
2017-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.93
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.93
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2017-06-30
Earnings History > 25 > report Date
2017-07-28
Earnings History > 25 > date
2017-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.23
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.23
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2017-03-31
Earnings History > 26 > report Date
2017-04-26
Earnings History > 26 > date
2017-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2016-09-30
Earnings History > 27 > report Date
2016-10-25
Earnings History > 27 > date
2016-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-08-01
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2013-12-31
Earnings History > 29 > report Date
2014-02-26
Earnings History > 29 > date
2013-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
0
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes. The company develops developing VIO-01, which is in Phase 1/2 of the VIO-01 clinical study, a Pan-DDR DNA decoy targeting multiple proteins and repair pathways in preclinical development; and PlatON, generates DecoyTAC combining DNA decoy molecules capable of cell penetration with a linker+E3 ligand. It also develops V-body platform, a bispecifics, ADCs, CAR-T, and V-body-oligonucleotide conjugates. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AALVIO.PA down 6.91% on 06 Jan 2026 after hours: 50-day avg €0.142 signals watchlist Meyka
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Valerio Therapeutics
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.